Preferred Pharmaceuticals, Inc recalls Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 coun
Recalled January 29, 2020 · FDA recall D-0797-2020 · Preferred Pharmaceuticals
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product. · FDA Class II
Units
39,172 tablets
Sold at
Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and SC
Description
CGMP Deviations: Presence of NDMA impurity detected in product.
Product
Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 count bottles (NDC: 68788-6382-9), d) 100 count bottles (NDC: 68788-6382-0)
Manufacturer(s)
Preferred Pharmaceuticals, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →